News & Opinion
15 May 2012Comments ( 4 )
Child psychiatrist and epidemiologist Eric Fombonne digs through the latest report on the prevalence of autism, suggesting reasons for the apparent increase in the disorder’s rates.
14 May 2012Comments ( 0 )
The past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.
11 May 2012Comments ( 2 )
Clinical trials for fragile X drugs should include a behavioral therapy component, says a parent of a child with the disorder.
11 May 2012Comments ( 0 )
Researchers have identified deletions in SHANK1 — the third member of a gene family that is closely linked to autism — in five men with the disorder, they reported 4 May in the American Journal of Human Genetics. This is the first study linking SHANK1 mutations to people with autism.
10 May 2012Comments ( 2 )
A genetic defect in the synthesis of carnitine, a molecule that is essential for proper mitochondrial function, might slightly increase risk for autism in some children, according to research published 8 May in the Proceedings of the National Academy of Sciences.